Trulicity

Trulicity price can vary by strength, pen quantity, and the supply being purchased. Review the amount shown for the exact pen strength before checkout, then make sure the number of pens matches the weekly schedule documented by your care team. A lower displayed amount may not be meaningful if it applies to a different strength or shorter supply.

When estimating Trulicity monthly cost, many people start with the number of once-weekly injections used in a typical month. That estimate should still be tied to the actual carton quantity and strength being purchased. If you are looking at Trulicity without insurance, focus on the complete cash-pay amount for that supply instead of comparing broad national averages.

• Strength: Match the milligram amount on your current label or treatment record.
• Quantity: Check how many pens are included in the supply.
• Total cost: Compare the full amount for the chosen strength and quantity.
• Handling: Refrigerated injections need temperature-conscious packing and storage.
• Continuity: Avoid changing strengths or restarting after a gap without clinical guidance.

Why it matters: Price comparisons are only useful when strength, quantity, and storage requirements are the same.

The GLP-1 agonists category can help you browse related medicines in the same class if your clinician has discussed alternatives.

Order Trulicity online by choosing the pen strength that matches your current treatment directions. Keep the carton, pharmacy label, or medication record nearby while ordering so the brand name, active ingredient, weekly strength, and quantity are consistent. If we need to review order details, we may ask for information that helps confirm the product and supply requested.

Trulicity from Canada may involve temperature-sensitive handling for US delivery from Canada. Dulaglutide pens are refrigerated products, so plan for an address where the package can be received promptly. The service may use prompt, express, cold-chain shipping when needed for refrigerated medicines, but you should still move the pens to a refrigerator soon after arrival.

Do not use online ordering to adjust your weekly dose, combine GLP-1 medicines, or switch from another diabetes injection on your own. Dose changes should be made with the healthcare professional managing your diabetes, especially if you also use insulin or medicines that increase insulin release.

Trulicity pens are single-patient injection devices used once weekly as directed. Product names and medication labels commonly show the strength as a milligram amount in a 0.5 mL pen. Read the strength and the quantity together, because the milligram amount does not tell you how many pens are included.

A Trulicity injection pen is not reusable for multiple weekly doses. Each pen strength should be treated as its own product choice during ordering. The carton strength, the active ingredient dulaglutide, and the weekly direction should all make sense together before a new supply is used.

Quick tip: Compare the milligram strength on your current pen carton with the strength chosen online before checkout.

Dulaglutide is used with diet and exercise to help improve blood sugar control in adults with type 2 diabetes. It may also be used to reduce the risk of major cardiovascular events in adults with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors.

Trulicity is not used to treat type 1 diabetes or diabetic ketoacidosis. It is also not a rapid-acting correction medicine for sudden high blood sugar. Your care plan may include glucose monitoring, nutrition changes, activity goals, and other diabetes medicines in addition to dulaglutide.

The type 2 diabetes section can help you browse related treatment categories. The broader diabetes category may also be useful if you are organizing supplies or comparing medication classes used in diabetes care.

Trulicity activates the GLP-1 receptor. GLP-1 receptor agonists are incretin-based medicines, meaning they mimic a natural hormone signal involved in blood sugar regulation. Dulaglutide can increase glucose-dependent insulin release, reduce glucagon secretion when glucose is high, and slow stomach emptying.

Those effects are why gastrointestinal symptoms are common, especially when treatment is started or changed. Slower stomach emptying may also affect how some oral medicines are absorbed. Tell your healthcare professional about medicines that require very predictable blood levels, including narrow-therapeutic-index drugs.

Blood sugar goals and A1C targets are individualized. Some people may notice appetite changes or weight changes while using GLP-1 medicines, but Trulicity should be evaluated primarily against the diabetes treatment goals set by the clinician managing your care.

Store Trulicity pens in a refrigerator at 2°C to 8°C, or 36°F to 46°F. Keep pens in the original carton to protect them from light. Do not freeze the pens, and do not use a pen that has been frozen.

Manufacturer instructions allow room-temperature storage up to 30°C, or 86°F, for up to 14 days. This can help during short trips or brief handling periods, but it does not replace normal refrigerated storage. Heat exposure, freezing, or damaged packaging should be treated as a reason to seek pharmacy or clinical guidance before use.

After receiving a temperature-sensitive order, place the pens in the refrigerator promptly and keep them separate from freezer areas or cooling elements. For travel, carry the pens with you rather than placing them in checked luggage, where temperatures can fluctuate. Keep the current medication label or documentation available if you need to identify the injection while traveling.

Common Trulicity side effects include nausea, diarrhea, vomiting, abdominal pain, decreased appetite, indigestion, and fatigue. These effects are often gastrointestinal and may be more noticeable around treatment starts or dose changes. Persistent vomiting, severe stomach pain, or signs of dehydration should be discussed with a healthcare professional promptly.

Trulicity carries a boxed warning about thyroid C-cell tumors observed in animal studies. It is contraindicated in people with a personal or family history of medullary thyroid carcinoma and in people with Multiple Endocrine Neoplasia syndrome type 2. Report a lump or swelling in the neck, trouble swallowing, hoarseness, or shortness of breath.

Serious risks can include pancreatitis, severe gastrointestinal disease, acute kidney injury, gallbladder disease, serious allergic reactions, and hypoglycemia when used with insulin or sulfonylureas. Seek urgent medical help for trouble breathing, swelling of the face or throat, severe abdominal pain that may radiate to the back, fainting, or severe dehydration.

Before using a new supply, make sure your care team knows about kidney problems, pancreatitis history, gallbladder disease, severe stomach or intestinal disease, diabetic eye disease, pregnancy, plans to become pregnant, or breastfeeding. Monitoring may include blood glucose trends, A1C, kidney function when clinically appropriate, side-effect tolerance, and hypoglycemia risk when Trulicity is combined with certain diabetes medicines.

Trulicity is used once weekly on the same day each week, according to individualized directions. If a dose is missed, follow the instructions provided by your healthcare professional or the official patient information rather than doubling doses. Do not take extra doses to make up for missed injections.

Low blood sugar is more likely when dulaglutide is used with insulin or sulfonylureas because those medicines can also lower glucose. If that combination is part of your plan, follow the glucose monitoring schedule you were given and keep fast-acting carbohydrate available as instructed.

Dulaglutide can slow gastric emptying, which means food and some medicines may leave the stomach more slowly. This is especially relevant for oral medicines where timing and absorption matter. Bring new medicines, supplements, and major diet changes to your clinician or pharmacist so they can assess interaction and monitoring needs.

Other diabetes medicines may be discussed when Trulicity is not tolerated, not suitable, or not the best fit for a patient’s goals. Comparisons should focus on active ingredient, dosing schedule, device type, storage, safety profile, and the condition being treated. Availability or cost should not be the only reason to change therapy.

The non-insulin diabetes medications category includes medicines that are not insulin. The broader diabetes medications category can help organize injectable and non-injectable choices discussed with a healthcare professional.

People who are also evaluating weight-related health goals may see GLP-1 medicines discussed in obesity or overweight care. Those treatment plans are not interchangeable with type 2 diabetes care. Browse obesity or overweight categories only as condition-based context, and ask a clinician which diagnosis and medication plan applies to you.

Official prescribing information and patient instructions are the best sources for indications, contraindications, injection technique, storage rules, and safety warnings. Compare the carton, medication label, and official instructions before using a new supply, especially after a strength change or treatment gap.

• Prescribing information: Confirms approved uses, boxed warnings, contraindications, adverse reactions, and interactions.
• Instructions for use: Explains pen handling, injection steps, storage, and disposal basics.
• Care-team directions: Clarify individualized glucose goals, missed-dose instructions, and combination therapy monitoring.

Authoritative references include the official prescribing information and the official instructions for use. Use those documents for clinical detail, and contact a healthcare professional if your strength, directions, or side effects do not match your current treatment plan.

This content is for informational purposes only and is not a substitute for professional medical advice.